10 Nov 2025

Syensqo’s Eviva^® Polysulfone selected by BIOTRONIK for pacemaker header components

The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability

Brussels, November 10, 2025 - Syensqo today announced that its Eviva^® Polysulfone (PSU) has been selected by BIOTRONIK, a global leader in medical technology, for use in the header of its latest Amvia Sky pacemaker models. Eviva^® PSU was chosen thanks to its outstanding biocompatibility, enabling indefinite implantation inside the human body, and its exceptional transparency, which supports precise electrode placement during surgical implantation.

Beyond transparency, Eviva^® PSU offers excellent mechanical strength and processability, allowing it to be molded into the intricate components required for pacemaker headers. It is manufactured at Syensqo’s ISO 13485 certified Alpharetta, Georgia site, with processes validated for medical applications and testing conducted in an ISO 17025 accredited laboratory.

“BIOTRONIK’s adoption of Eviva^® PSU for its pacemaker header is a powerful endorsement of our Solviva^® Biomaterials portfolio,” said Federico Baruffi, Global Marketing Manager at Syensqo. “The material’s combination of transparency, biocompatibility, and reliable processability provides critical value for life-saving cardiac implants.”

The application of Eviva^® PSU in pacemakers reflects a broader trend toward miniaturization, longevity, and remote monitoring in cardiac devices. The material also shows potential in neurostimulation devices, such as brain stimulators.

BIOTRONIK’s selection of Eviva^® PSU underscores Syensqo’s commitment to supporting medical device innovation with high-performance materials.

Eviva^® and Solviva^® are registered trademarks of Syensqo.

Reader enquiries

Syensqo
Rue de la Fusée 98
1130 Brussels
Belgium

channel/UC2llMaHNTklvl8N4gwSiuRw

Notes for editors

About Syensqo

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Learn more at www.syensqo.com.

About BIOTRONIK

For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology.

Learn more at www.biotronik.com.